Literature DB >> 15126169

Acute myeloid leukemia presenting as bilateral proptosis from diffuse extraocular muscle infiltration.

Eric Chen1, David G Morrison, Sean P Donahue.   

Abstract

PURPOSE: To report a case of acute myeloid leukemia with bilateral proptosis as the sole presenting sign.
DESIGN: Observational case report.
METHODS: A patient with bilateral proptosis was seen in consultation by pediatric ophthalmology.
RESULTS: Complete blood count, computerized tomography, and bone marrow biopsy confirmed the diagnosis of acute myeloid leukemia, with the proptosis due to diffuse infiltration of all extraocular muscles.
CONCLUSION: In a child with the sudden onset of proptosis without any other systemic findings, the diagnosis of acute leukemia must be considered.

Entities:  

Mesh:

Year:  2004        PMID: 15126169     DOI: 10.1016/j.ajo.2003.10.050

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Intramuscular leukemic relapse: clinical signs and imaging findings. A multicentric analysis.

Authors:  Alexey Surov; Hayyam Kiratli; Soo Ah Im; Yasuhiro Manabe; Alibhe O'Neill; Atul B Shinagare; Rolf Peter Spielmann
Journal:  Skeletal Radiol       Date:  2014-09-26       Impact factor: 2.199

2.  Diplopia as the presenting feature of acute lymphoblastic leukemia.

Authors:  A T Burshina; Rajasekar Thirugnanam; Arul Selvan; C Seetharaman; Mani Karthik Kumar; Sangita S Mehta; Virna M Shah
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-17

Review 3.  Early Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives.

Authors:  Nasrine Anais El Salloukh; Dany G Hage; Anna Z Bashshur; Wajiha Jurdi Kheir
Journal:  Clin Ophthalmol       Date:  2022-07-01

4.  Bilateral orbital myeloid sarcoma as initial manifestation of acute myeloid leukemia.

Authors:  Kamel Hmidi; Sonia Zaouali; Riadh Messaoud; Bahri Mahjoub; Wafa Ammari; Leila Bacha; Adnene Laatiri; Salah Jenzeri; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2007-05-24       Impact factor: 2.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.